Mednax Inc (MD) has risen sharply, recording gains of 0.73% in the past 4 weeks. However, the stock has corrected -1.26% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 2.81% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.
The stock has recorded a 20-day Moving Average of 0.59% and the 50-Day Moving Average is 5.43%.The 200 Day SMA reached 4.9% MEDNAX, Inc. has dropped 5.52% during the last 3-month period . Year-to-Date the stock performance stands at -9.21%.
Mednax Inc (MD) : The consensus price target for Mednax Inc (MD) is $75.71 for the short term with a standard deviation of $3.25. The most optimist securities analyst among the 7 who monitor the stock believes that the stock can reach $80, however, the pessimist price target for the company is $70.
For the current week, the company shares have a recommendation consensus of Buy. Mednax Inc (NYSE:MD): stock was range-bound between the intraday low of $64.63 and the intraday high of $65.45 after having opened at $65.08 on Fridays session. The stock finally closed in the red at $65.08, a loss of -0.31%. The stock remained in the red for the whole trading day. The total traded volume was 1,023,741 shares. The stock failed to cross $65.45 in Fridays trading. The stocks closing price on Thursday was $65.06.
MEDNAX, Inc. (MEDNAX) is a provider of physician services, including newborn, maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units, primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals, 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists and pediatric surgeons.